QPI-1002 Phase III for AKI
QPI-1002 Phase III for DGF
QPI-1007 Phase II/III for NAION
Check our products

Quark Pharmaceuticals, Inc. is a late-stage pharmaceutical company and a leader in the discovery and development of novel siRNA therapeutics

Promising siRNA therapeutics targeting different genes for different indications and target organs

We have a fully integrated Research and Development team with a proven track record of translating our innovations in siRNA therapeutics from discovery to the clinic.

We have full capabilities in the areas of cell and molecular biology, protein biochemistry, monoclonal antibody technology, bioinformatics, animal pharmacology, histopathology including immunohistochemistry and in situ hybridization, and drug delivery. Our development teams, to-date have progressed drug candidates through INDs into advanced clinical studies in different disease indications.